HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael J Petris Selected Research

Zinc

3/2007A histidine-rich cluster mediates the ubiquitination and degradation of the human zinc transporter, hZIP4, and protects against zinc cytotoxicity.
3/2004Acrodermatitis enteropathica mutations affect transport activity, localization and zinc-responsive trafficking of the mouse ZIP4 zinc transporter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael J Petris Research Topics

Disease

14Menkes Kinky Hair Syndrome (Menkes Disease)
01/2020 - 11/2002
5Inborn Genetic Diseases (Disease, Hereditary)
10/2023 - 02/2004
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016 - 12/2012
4Neoplasms (Cancer)
01/2022 - 01/2019
3Inflammation (Inflammations)
01/2022 - 10/2012
3Infections
01/2020 - 04/2012
3Hepatolenticular Degeneration (Wilson's Disease)
01/2016 - 11/2002
3Bacterial Infections (Bacterial Infection)
04/2014 - 12/2009
2Fibrosis (Cirrhosis)
01/2024 - 01/2015
2Melanoma (Melanoma, Malignant)
01/2023 - 03/2015
2Neoplasm Metastasis (Metastasis)
01/2022 - 01/2019
2Carcinogenesis
06/2020 - 01/2019
2Sialadenitis
10/2017 - 10/2012
2Seizures (Absence Seizure)
11/2015 - 06/2015
2Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease)
06/2015 - 01/2012
2Alzheimer Disease (Alzheimer's Disease)
04/2014 - 09/2010
2Acrodermatitis enteropathica
03/2007 - 03/2004
1Xerostomia
01/2024
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2024
1Hypopigmentation (Hypomelanosis)
01/2023
1Dacryocystitis (Dacryoadenitis)
01/2022
1Starvation
01/2021
1Squamous Cell Carcinoma of Head and Neck
06/2020
1Mouth Neoplasms (Oral Cancer)
06/2020
1Body Weight (Weight, Body)
12/2019
1Carcinoma (Carcinomatosis)
01/2019
1Breast Neoplasms (Breast Cancer)
01/2019
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2017
1Salmonella Infections (Salmonellosis)
01/2017
1Demyelinating Diseases (Demyelinating Disease)
11/2015
1Ataxia (Dyssynergia)
11/2015
1Intellectual Disability (Idiocy)
11/2015
1Muscular Atrophy (Muscle Atrophy)
06/2015
1Failure to Thrive
06/2015
1Muscle Hypotonia (Hypotonia)
06/2015
1Peptic Ulcer (Peptic Ulcers)
03/2015
1Disease Progression
06/2013
1Amyloid Plaque
09/2010
1Hypoxia (Hypoxemia)
05/2009
1Deficiency Diseases (Deficiency Disease)
03/2007

Drug/Important Bio-Agent (IBA)

24CopperIBA
01/2022 - 11/2002
9P-type ATPasesIBA
12/2019 - 11/2002
7Proteins (Proteins, Gene)FDA Link
10/2023 - 11/2002
5Copper-Transporting ATPasesIBA
12/2019 - 10/2007
4Adenosine Triphosphatases (ATPase)IBA
01/2020 - 11/2002
4Copper Transport ProteinsIBA
01/2017 - 01/2012
3NucleotidesIBA
06/2020 - 10/2012
3EnzymesIBA
01/2019 - 10/2007
2CollagenIBA
01/2024 - 01/2015
2Superoxide DismutaseIBA
01/2021 - 05/2009
2CytokinesIBA
01/2015 - 06/2013
2ZincIBA
03/2007 - 03/2004
1Fibrillar CollagensIBA
01/2024
1Melanins (Melanin)IBA
01/2023
1Phenolsulfonphthalein (Phenol Red)IBA
01/2022
1Purinergic Receptors (Receptors, Purine)IBA
01/2022
1MetalsIBA
01/2022
1AR-C118925IBA
06/2020
1Indicators and Reagents (Reagents)IBA
06/2020
1Uridine Triphosphate (UTP)IBA
06/2020
1Fura-2 (Fura 2)IBA
06/2020
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2020
1Purinergic P2Y2 ReceptorsIBA
06/2020
1ErbB Receptors (EGF Receptor)IBA
06/2020
1Transferrin (beta 2 Transferrin)IBA
01/2020
1elesclomolIBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
12/2019
1Insulin (Novolin)FDA Link
12/2019
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2019
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2019
1Carbachol (Carbastat)FDA Link
10/2017
1Purinergic P2X7 ReceptorsIBA
10/2017
13- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA
10/2017
1N-Methylaspartate (NMDA)IBA
11/2015
1Proton Pump InhibitorsIBA
03/2015
1Omeprazole (Prilosec)FDA LinkGeneric
03/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2015
14- (4- (3- (pyridin- 2- yl)- 1H- pyrazol- 4- yl)pyridin- 2- yl)- N- (tetrahydro- 2H- pyran- 4- yl)benzamideIBA
01/2015
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
01/2015
1Fibronectins (Fibronectin)IBA
01/2015
1AllergensIBA
04/2014
1GTP-Binding Proteins (G-Protein)IBA
04/2014
1Actin Depolymerizing Factors (Cofilins)IBA
06/2013
1Peptides (Polypeptides)IBA
09/2010
1Amyloid (Amyloid Fibrils)IBA
09/2010
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
05/2009
1Ceruloplasmin (Ferroxidase)IBA
05/2009
1zinc-binding protein (zinc binding protein)IBA
03/2004
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2002

Therapy/Procedure

3Therapeutics
01/2024 - 06/2020
1Radiotherapy
01/2024
1Denervation
06/2015
1Ligation
01/2015